A controlled trial of rasagiline in early Parkinson Disease. Arch Neurol 2002;59:1937-1943.
Group, Parkinson Study. 2002. “A Controlled Trial of Rasagiline in Early Parkinson Disease. Arch Neurol 2002;59:1937-1943.”. Arch Neurol.
Search
Search results
134 results found
Learning Fun!
Amanda enjoyed her training in Canada!
Pardoprunox in early Parkinson's disease: Results from 2 large, randomized double-blind trials. Mov Disord 2011;26:1464-76.
Sampaio, C, J Bronzova, RA Hauser, AE Lang, O Rascol, SV Van De Witte, and AA Theeuwes. 2011. “Pardoprunox in Early Parkinson’s Disease: Results from 2 Large, Randomized Double-Blind Trials. Mov Disord 2011;26:1464-76.”. Mov Disord.
A double-blind, delayed-start trial of rasagiline in Parkinson's disease (the ADAGIO study): prespecified and post-hoc analyses of the need for additional therapies, changes in UPDRS scores, and non-motor outcomes
Rascol, O, CJ Fitzer-Attas, RA Hauser, J Jankovic, A Lang, JW Langston, E Melamed, et al. 2011. “A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinson’s Disease (the ADAGIO Study): Prespecified and Post-Hoc Analyses of the Need for Additional Therapies, Changes in UPDRS Scores, and Non-Motor Outcomes”. Lancet Neurol.
Clinical vignettes in Parkinson's disease: a collection of unusual medication-induced hallucinations, delusions, and compulsive behaviours.
Friedman, JH, P Agarwal, R Alcalay, KJ Black, KL Chou, L Cote, P Dayalu, et al. 2011. “Clinical Vignettes in Parkinson’s Disease: A Collection of Unusual Medication-Induced Hallucinations, Delusions, and Compulsive Behaviours.”. Int J Neurosci.
Crossover comparison of IPX066 and a standard levodopa formulation in advanced Parkinson's disease.
Hauser, RA, AL Ellenbogen, LV Metman, A Hsu, MJ O’Connell, NB Modi, HM Yao, SH Kell, and SK Gupta. 2011. “Crossover Comparison of IPX066 and a Standard Levodopa Formulation in Advanced Parkinson’s Disease.”. Mov Disord.
Long-term treatment with botulinum toxin type A in cervical dystonia has low immunogenicity by mouse protection assay.
Brin, MF, CL Comella, J Jankovic, F Lai, M Naumann, and BoNTA Study Group. 2008. “Long-Term Treatment With Botulinum Toxin Type A in Cervical Dystonia Has Low Immunogenicity by Mouse Protection Assay.”. Mov Disord.
Transplanted dopaminergic neurons develop PD pathologic changes: a second case report
Kordower, JH, Y Chu, RA Hauser, CW Olanow, and TB Freeman. 2008. “Transplanted Dopaminergic Neurons Develop PD Pathologic Changes: A Second Case Report”. Mov Disord.
Pregabalin (Lyrica) in the treatment of Essential Tremor.
Zesiewicz, TA, CL Ward, RA Hauser, JA Pease Campbell, and KL Sullivan. 2007. “Pregabalin (Lyrica) in the Treatment of Essential Tremor.”. Movement Disorders.
Duodenal levodopa infusion for the treatment of Parkinson’s disease.
Samanta, J, and RA Hauser. 2007. “Duodenal Levodopa Infusion for the Treatment of Parkinson’s Disease.”. Expert Opinion Pharmacother.